Results 111 to 120 of about 8,158 (292)

Incretins and their influence on the course of type 2 diabetes in patients with morbid obesity after bariatric oper

open access: yes, 2012
Most researchers support the important role of incretins, particularly glucagon-like peptide-1 in improving metabolic control in patients with type 2 diabetes after bariatric operations, mostly involving shunting.

core   +2 more sources

The use of incretins and fractures - a meta-analysis on population-based real life data

open access: yes, 2017
Item does not contain fulltextThe aim of the present study was to estimate the effect of incretins on fracture risk in the real-world situation by meta-analysis of the available population-based cohort data.
Henry, R.M.   +38 more
core   +2 more sources

Multivalent antibody‐based conjugates as new tools for tailored modulation of G protein–coupled receptors

open access: yesBritish Journal of Pharmacology, EarlyView.
The G protein–coupled receptor (GPCR) superfamily consists of the most common targets of approved drugs. Targeting GPCRs offers appealing avenues for therapeutic development. Antibodies and their fragments, such as single‐domain antibodies (VHHs or nanobodies), have emerged as useful alternatives to small molecule pharmacophores as building blocks in ...
Shivani Sachdev, Ross W. Cheloha
wiley   +1 more source

The Pharmacologic Exploitation of Pleiotropic Effect of Incretins

open access: yes
This thesis aims to explore the various effects of incretins on the many systems of the body and how they can be utilized pharmacologically. It will investigate their use in treatment for diabetes mellitus type 2, which they were initially introduced as ...
Khan, Tazeen
core  

Women with COPD by biomass show different serum profile of adipokines, incretins, and peptide hormones than smokers

open access: yes, 2018
Background The main causes of COPD are tobacco smoking (COPD-TS) and biomass smoke exposure (COPD-BS). COPD-TS is known to induce changes in adipokines, incretins, and peptide hormones, frequent biomarkers of inflammation; however, it is unknown if ...
Yadira Velasco-Torres   +8 more
core   +1 more source

Peripheral targets for neuropathic pain

open access: yesBritish Journal of Pharmacology, EarlyView.
Neuropathic pain represents a significant clinical challenge, with still limited pharmacological approaches to symptomatic relief. This review focuses on molecular targets implicated in neuropathic pain, particularly those involved in peripheral mechanisms. Using the IUPHAR/BPS database of biological targets, their occurrence together with ‘neuropathic
Amirhossein Afsharipour   +3 more
wiley   +1 more source

Re‐thinking peripheral dysfunctions in obesity: The emerging role of sulphaceutics and sulphanutraceutics

open access: yesBritish Journal of Pharmacology, EarlyView.
Obesity is a chronic, relapsing, multisystem disease in which cardiometabolic risk arises from excess adiposity and progressive dysfunction of peripheral organs, ultimately disrupting endocrine and metabolic crosstalk among tissues. Within this network, sulphur‐based biology, centred on hydrogen sulphide and related reactive sulphur species, has ...
Martina Smimmo   +4 more
wiley   +1 more source

Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy

open access: yes, 2002
Objective: Although the incretins, gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), as well as glucagon and cortisol, are known to influence islet function, the role of these hormones in conditions of insulin resistance and ...
Forsberg, H   +14 more
core   +1 more source

From narratives to numbers and back: Assessing the psychosocial aspects of diabetes in the era of high technology with emerging qualitative and quantitative methodologies

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Rapid changes in diabetes therapy combined with limitations of traditional methodological approaches challenge the field of psychosocial research to adequately capture the experiences of people with diabetes. This narrative review provides an overview of emerging qualitative and quantitative approaches that can advance the study of ...
Dominic Ehrmann   +11 more
wiley   +1 more source

Incretins and diabetes mellitus type 2 - from pathophysiology to therapeutic treatment [PDF]

open access: yes, 2014
Moderni terapijski pristup liječenju šećerne bolesti tipa 2 usmjeren je na povećanje razine inkretinskih hormona u cirkulaciji. Inkretini su endogeni regulatorni peptidi koje izlučuju stanice crijeva i koji potiču otpuštanje inzulina, inhibiraju ...
Ranđelović, Karla
core  

Home - About - Disclaimer - Privacy